Comparing robotic and video-assisted surgery for early-stage lung cancer
Official title: Comparing Outcomes for Minimally Invasive Techniques for Anatomic Lung Resection for Cancer - A Prospective, Comparative, Non-randomized, Open Label Post-market Observational Cohort Study Within Europe
Run by Intuitive Surgical · NCT06038227 · Data updated 2026-11-12
This study is testing whether robotic surgery or video-assisted surgery is better for people with early-stage lung cancer to see how they recover and feel afterwards.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Intuitive Surgical Industry-sponsored |
| Locations | 13 sites (Copenhagen and 12 other locations) |
| Status | Recruiting |
| Started | July 15, 2023 |
| Main results expected | December 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT06038227 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older diagnosed with clinical stage IA1-2 non-small cell lung cancer scheduled for minimally invasive surgery.
✕Probably not a fit
Patients with more advanced stages of lung cancer or those requiring emergency surgical procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the outcomes of minimally invasive surgical techniques, specifically robotic-assisted thoracic surgery (RATS) and video-assisted thoracic surgery (VATS), for treating early-stage non-small cell lung cancer (NSCLC). It focuses on patients diagnosed with clinical stage IA1-2 lung cancer who are scheduled for these surgical procedures. The study will evaluate perioperative outcomes and the real-world selection process for these techniques, while also assessing health-related quality of life to provide insights into recovery times and disease burden.
Why it matters
Potential benefit: If successful, this study could enhance surgical options and outcomes for patients with early-stage lung cancer.
How similar studies have gone: Previous studies have shown promising results for robotic-assisted surgeries in lung cancer, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient diagnosed with clinical stage IA1-2 non-small cell lung cancer at time of procedure * Patient scheduled to undergo minimally invasive surgery for NSCLC with either da Vinci robotic assisted surgery or VATs * Aged ≥ 18 years * Must be willing and able to comply with study requirements * Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form Exclusion Criteria: * Patients with clinical stage IA3, II, III, and IV lung cancer * Patient receiving a lobectomy/segmentectomy as an emergency procedure * Patients receiving a lobectomy/segmentectomy for metastatic cancer * Patients scheduled to receive a bilobectomy or sleeve-lobectomy * Mental incapacity to understand or consent to study procedures * Anticipated difficulty for patient to comply with protocol requirements * Unable to comply with the follow up schedule * Pregnant or are planning to become pregnant during the study * Life expectancy \< 12 months
Where it's running
-
Copenhagen University Hospital Rigshospitalet
Copenhagen, Denmark Recruiting -
Ap-Hm
Marseille, France Recruiting -
CHU de Rouen
Rouen, France Recruiting -
CHU de Toulouse
Toulouse, France Recruiting -
Thoraxklinik
Heidelberg, Germany Recruiting -
Krankenhaus Barmherzige Brüder
Regensburg, Germany Recruiting
Show 7 more locations
-
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy Recruiting -
Akershus University Hospital
Loerenskog, Norway Recruiting -
University Hospital Zurich
Zurich, Switzerland Recruiting -
University Hospitals Bristol and Weston NHS Foundation Trust
Bristol, United Kingdom Recruiting -
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, United Kingdom Recruiting -
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom Recruiting -
St Bartholomew Hospital
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Tom Routledge — Guy's St Thomas' NHS Foundation Trust, UK
- Study coordinator: Marie Allouis
- Email: Marie.Allouis@intusurg.com
- Phone: +33786480495
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.